HB2600 creates the COVID-19 Vaccination Employer Mandate Prohibition Act and makes it unlawful for an employer in Illinois to create, implement, or enforce a workplace vaccination program that requires employees to show proof of receiving a COVID-19 vaccine or booster authorized by the U.S. Food and Drug Administration under emergency use authorization. The bill is framed as an employment measure and takes effect immediately if enacted.
The bill states a legislative purpose of protecting bodily autonomy and argues that emergency-use-authorized vaccines have not been studied long enough for their short- and long-term effects. It also asserts that because COVID-19 is no longer a pandemic, vaccine mandates are no longer necessary. In practical terms, the bill would bar Illinois employers from conditioning employment on proof of receipt of an EUA COVID-19 vaccine or booster.
Impact
If enacted, HB2600 would add a new state prohibition limiting employer vaccination policies in Illinois. It would affect private and public employers operating in the state by preventing workplace rules that require employees to demonstrate receipt of a COVID-19 vaccine or booster authorized under federal emergency use authority. The bill would not ban vaccination itself, but it would restrict employer enforcement of proof-based COVID-19 vaccine mandates as a condition of employment.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes, the available sentiment is primarily reflected in the sponsor’s framing: strongly supportive of individual choice and opposed to employer vaccine mandates. The measure appears to be introduced as a response to COVID-19 workplace requirements and is presented as a protection for employee autonomy. No contrary testimony or recorded vote history is available in the provided materials.
Contention
The main point of contention is the balance between employee bodily autonomy and employer authority to set workplace health and safety policies. Supporters, as reflected in the bill text, argue that emergency-use-authorized vaccines should not be mandated and that COVID-19 no longer justifies such requirements. Opponents would likely focus on employers’ ability to manage workplace risk and public health, especially in settings where vaccination policies are used to protect workers, customers, or vulnerable populations. No committee transcript or vote record is provided to show how these arguments were raised in debate.